Related Experiment Video
Updated: Jun 6, 2026

10:03
A Zebrafish Model of Diabetes Mellitus and Metabolic Memory
Published on: February 28, 2013
Epigenetics: mechanisms and implications for diabetic complications.
1Baker IDI Heart and Diabetes Institute, Monash University, Victoria, Australia.
Circulation Research
|December 15, 2010
Summary
Transient hyperglycemia causes lasting epigenetic changes, contributing to diabetic vascular complications. Understanding these epigenetic modifications offers new therapeutic targets for diabetes.
Area of Science:
- Molecular Biology
- Epigenetics
- Endocrinology
Background:
- Epigenetic modifications are crucial for chromosome metabolism and cellular function.
- Hyperglycemic memory is a key challenge in understanding diabetes and its long-term complications.
- The precise molecular mechanisms linking hyperglycemic memory to diabetic vascular complications are not fully understood.
Purpose of the Study:
- To investigate the role of epigenetic modifications in the development of diabetic vascular complications.
- To explore the link between transient hyperglycemia, epigenetic changes, and cellular memory.
- To identify potential therapeutic targets by understanding enzymes involved in epigenetic regulation.
Main Methods:
- Analysis of chemical modifications on the H3 histone tail (lysine 4 and 9).
- Examination of gene expression changes conferred by hyperglycemia.
- Assessment of epigenetic determinant persistence in models of glycemic variability and diabetic complications.
Main Results:
- Hyperglycemia induces gene-activating epigenetic changes, specifically modifying H3 histone tails.
- These epigenetic changes can persist, conferring a cellular memory of glycemic events.
- Transient hyperglycemia promotes signaling events critical for vascular complication development.
Conclusions:
- Epigenetic modifications, particularly H3 histone changes, play a critical role in mediating the long-term effects of hyperglycemia.
- Understanding the enzymes that regulate these epigenetic marks is vital for deciphering diabetic vascular injury.
- Targeting epigenetic pathways may offer novel therapeutic strategies for managing diabetic complications.
Related Concept Videos
Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Complications of Diabetes Mellitus
Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...
Pathophysiology of Diabetes
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Diabetes Mellitus: Introduction
Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...
Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
